Artwork

内容由Women in Ophthalmology提供。所有播客内容(包括剧集、图形和播客描述)均由 Women in Ophthalmology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

S01E01 Rituximab for Non-infectious Uveitis and Scleritis

11:07
 
分享
 

Manage episode 308189743 series 3011762
内容由Women in Ophthalmology提供。所有播客内容(包括剧集、图形和播客描述)均由 Women in Ophthalmology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Is Rituximab a Wonder-drug?

Dr Diana Conrad, Director of the Uveitis Service at the Royal Women’s and Children’s Hospital (the only speciality uveitis service in Queensland) explores a review paper on the use of rituximab for the treatment of non-infectious uveitis and scleritis. Dr Conrad notes an impressive response rate to rituximab for patients where first and second-line treatments have failed. Given the success of rituximab, and the biosimilars entering the market, Dr Conrad includes some important messages for ophthalmologists using the drug.
View article here

  continue reading

20集单集

Artwork
icon分享
 
Manage episode 308189743 series 3011762
内容由Women in Ophthalmology提供。所有播客内容(包括剧集、图形和播客描述)均由 Women in Ophthalmology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Is Rituximab a Wonder-drug?

Dr Diana Conrad, Director of the Uveitis Service at the Royal Women’s and Children’s Hospital (the only speciality uveitis service in Queensland) explores a review paper on the use of rituximab for the treatment of non-infectious uveitis and scleritis. Dr Conrad notes an impressive response rate to rituximab for patients where first and second-line treatments have failed. Given the success of rituximab, and the biosimilars entering the market, Dr Conrad includes some important messages for ophthalmologists using the drug.
View article here

  continue reading

20集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放